1
|
Puttaswamy H, Gowtham HG, Ojha MD, Yadav A, Choudhir G, Raguraman V, Kongkham B, Selvaraju K, Shareef S, Gehlot P, Ahamed F, Chauhan L. In silico studies evidenced the role of structurally diverse plant secondary metabolites in reducing SARS-CoV-2 pathogenesis. Sci Rep 2020; 10:20584. [PMID: 33239694 PMCID: PMC7689506 DOI: 10.1038/s41598-020-77602-0] [Citation(s) in RCA: 48] [Impact Index Per Article: 9.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/21/2020] [Accepted: 11/04/2020] [Indexed: 12/23/2022] Open
Abstract
Plants are endowed with a large pool of structurally diverse small molecules known as secondary metabolites. The present study aims to virtually screen these plant secondary metabolites (PSM) for their possible anti-SARS-CoV-2 properties targeting four proteins/ enzymes which govern viral pathogenesis. Results of molecular docking with 4,704 ligands against four target proteins, and data analysis revealed a unique pattern of structurally similar PSM interacting with the target proteins. Among the top-ranked PSM which recorded lower binding energy (BE), > 50% were triterpenoids which interacted strongly with viral spike protein-receptor binding domain, > 32% molecules which showed better interaction with the active site of human transmembrane serine protease were belongs to flavonoids and their glycosides, > 16% of flavonol glycosides and > 16% anthocyanidins recorded lower BE against active site of viral main protease and > 13% flavonol glycoside strongly interacted with active site of viral RNA-dependent RNA polymerase. The primary concern about these PSM is their bioavailability. However, several PSM recorded higher bioavailability score and found fulfilling most of the drug-likeness characters as per Lipinski's rule (Coagulin K, Kamalachalcone C, Ginkgetin, Isoginkgetin, 3,3'-Biplumbagin, Chrysophanein, Aromoline, etc.). Natural occurrence, bio-transformation, bioavailability of selected PSM and their interaction with the target site of selected proteins were discussed in detail. Present study provides a platform for researchers to explore the possible use of selected PSM to prevent/ cure the COVID-19 by subjecting them for thorough in vitro and in vivo evaluation for the capabilities to interfering with the process of viral host cell recognition, entry and replication.
Collapse
Affiliation(s)
- Hariprasad Puttaswamy
- Centre for Rural Development and Technology, Indian Institute of Technology Delhi, New Delhi, Delhi, 110016, India.
| | | | - Monu Dinesh Ojha
- Centre for Rural Development and Technology, Indian Institute of Technology Delhi, New Delhi, Delhi, 110016, India
| | - Ajay Yadav
- Centre for Rural Development and Technology, Indian Institute of Technology Delhi, New Delhi, Delhi, 110016, India
| | - Gourav Choudhir
- Centre for Rural Development and Technology, Indian Institute of Technology Delhi, New Delhi, Delhi, 110016, India
| | - Vasantharaja Raguraman
- Centre for Rural Development and Technology, Indian Institute of Technology Delhi, New Delhi, Delhi, 110016, India
| | - Bhani Kongkham
- Centre for Rural Development and Technology, Indian Institute of Technology Delhi, New Delhi, Delhi, 110016, India
| | - Koushalya Selvaraju
- Centre for Rural Development and Technology, Indian Institute of Technology Delhi, New Delhi, Delhi, 110016, India
| | - Shazia Shareef
- Centre for Rural Development and Technology, Indian Institute of Technology Delhi, New Delhi, Delhi, 110016, India
| | - Priyanka Gehlot
- Centre for Rural Development and Technology, Indian Institute of Technology Delhi, New Delhi, Delhi, 110016, India
| | - Faiz Ahamed
- Centre for Rural Development and Technology, Indian Institute of Technology Delhi, New Delhi, Delhi, 110016, India
| | - Leena Chauhan
- Centre for Rural Development and Technology, Indian Institute of Technology Delhi, New Delhi, Delhi, 110016, India
| |
Collapse
|